Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (4): 793-797. doi: 10.19723/j.issn.1671-167X.2021.04.029

Previous Articles     Next Articles

Strategy of reoperation for pheochromocytoma and paraganglioma

LIU Lei,QIN Yan-chun,WANG Guo-liang,ZHANG Shu-dong,HOU Xiao-fei,MA Lu-lin()   

  1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
  • Received:2021-03-22 Online:2021-08-18 Published:2021-08-25
  • Contact: Lu-lin MA E-mail:malulin@medmail.com.cn

RICH HTML

  

Abstract:

Objective: To explore the surgical strategy and experience of reoperation for pheochromocytoma and paraganglioma which is very challenging. Methods: The clinical data of 7 patients with pheochromocytoma and paraganglioma who underwent reoperation in Department of Urology, Peking University Third Hospital from August 2016 to February 2021 were analyzed retrospectively. There were 4 males and 3 females, with an average age of (44.1±11.5) years (28-60 years), 6 cases on the right side and 1 case on the left side. The causes of the operations included: (1) 2 cases of tumor recurrence after resection; (2) The primary operations failed to completely remove the tumors in 3 cases, because the tumors were large and closely related to blood vessels. (3) Pheochromocytoma and paraganglioma wasn’t diagnosed before primary operation, therefore, drug preparation wasn’t prepared. Two cases were interrupted by severe blood pressure fluctuations during the primary operations. Imaging evaluation, catecholamine biochemical examination and adequate adrenergic α receptor blockers were administrated in all the cases. The surgical approaches included open transperitoneal surgery in 4 cases, robot-assisted laparoscopy in 1 case and retroperitoneal laparoscopy in 2 cases. The innovative techniques included mobilization of the liver, inferior vena cava transection and anastomosis, and transection of left renal vein. Results: The average tumor size was (8.0±3.2) cm (3.6-13.9 cm). The median interval between the reoperation and the primary operation was 9 months (IQR: 6,19 months). The median operation time was 407 min (IQR: 114, 430 min) and the median blood loss was 1 500 mL (IQR: 20, 3 800 mL). Operations of 5 cases were performed successfully, and 1 case failed only by exploration during the operation. One case died perioperatively. There were 5 cases of intraoperative blood transfusion, the median transfusion volume of red blood cells was 800 mL (IQR: 0, 2 000 mL). One case experienced postoperative lymphorrhagia, and recovered after conservative treatment. The renal function was normal in 2 cases after resection and anastomosis of inferior vena cava or transection of left renal vein. The average postoperative hospital stay was (7.2±3.3) d (4-13 d). The median follow-up time of 6 patients was 33.5 months (IQR: 4.8, 48.0 months). The case who failed in the reoperation still survived with tumor and there was no recurrence in the rest of the patients. Conclusion: The reoperation of pheochromocytoma and paraganglioma, which can not be resected in the primary operation or recurred postoperatively, is difficult with high risk of hemorrhage, and there is a risk of failure and perioperative death. Different surgical approaches and strategies need to be adopted based on the different situation.

Key words: Pheochromocytoma, Paraganglioma, Reoperation, Recurrence

CLC Number: 

  • R737.1

Figure 1

Preoperative imaging of cases who underwent reoperation of pheochromocytoma and paraganglioma A-G, cases 1-7."

Table 1

Clinical data of patients and operations"

Items Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7
Gender Female Female Male Male Male Male Female
Age/years 36 28 49 33 45 58 60
Side Right Right Right Right Right Right Left
Interval to primary surgery/months 108 9 6 6 18 1 19
BMI/ (kg/m2) 20.9 25.8 26.0 21.5 27.2 27.3 32.8
ASA 2 2 2 2 3 2 2
Size/cm 8.7 13.9 9.2 7.4 7.4 3.6 5.9
Location Retrohepatic Retrocaval Retrocaval Retrocaval Retrocaval Normal Para-aortic
Preoperative albumin/ (g/L) 45.6 42.2 46.7 48.6 48.8 43.3 45.8
Preoperative total protein/ (g/L) 69.0 65.6 76.3 74.5 77.7 69.0 75.3
Preoperative hemoglobin/ (g/L) 141.0 87.0 136.0 144.0 154.0 136.0 135.0
Postoperative hemoglobin/ (g/L) 125.0 123.0 103.0 115.0 128.0 120.0
Operation time /min 421 430 407 520 283 111 114
Blood loss/mL 1 500 12 000 1 600 1 500 3 800 20 20
Complication Dead Failed to
resect tumor
Lymphorrhagia
Approach Open Open Open Open Robotic Laparoscopic Laparoscopic
Blood transfusion volume/mL 800 5000 1600 800 2000 0 0
Innovative technique Mobilization
of the liver
Resection and
anastomosis of IVC
Transection of
left renal vein
Postoperative hospital stay/d 6 6 9 13 5 4
Followup /months 46 39 28 1 54 6
Outcome No recurrence Dead No recurrence No recurrence No recurrence No recurrence No recurrence
[1] Hamidi O, Young WF Jr., Iñiguez-Ariza NM, et al. Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years [J]. J Clin Endocrinol Metab, 2017, 102(9):3296-3305.
doi: 10.1210/jc.2017-00992
[2] Davison AS, Jones DM, Ruthven S, et al. Clinical evaluation and treatment of phaeochromocytoma [J]. Ann Clin Biochem, 2018, 55(1):34-48.
doi: 10.1177/0004563217739931 pmid: 29027806
[3] Hamidi O, Young WF Jr., Gruber L, et al. Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A syste-matic review and meta-analysis [J]. Clin Endocrinol (Oxf), 2017, 87(5):440-450.
doi: 10.1111/cen.2017.87.issue-5
[4] Lam AK. Update on adrenal tumours in 2017 World Health Orga-nization (WHO) of endocrine tumours [J]. Endocr Pathol, 2017, 28(3):213-227.
doi: 10.1007/s12022-017-9484-5
[5] Wilhelm SM, Prinz RA, Barbu AM, et al. Analysis of large versus small pheochromocytomas: Operative approaches and patient outcomes [J]. Surgery, 2006, 140(4):553-560.
doi: 10.1016/j.surg.2006.07.008
[6] Amar L, Servais A, Gimenez-Roqueplo AP, et al. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma [J]. J Clin Endocrinol Metab, 2005, 90(4):2110-2116.
doi: 10.1210/jc.2004-1398
[7] Edstrom Elder E, Hjelm Skog AL, Hoog A, et al. The management of benign and malignant pheochromocytoma and abdominal paraganglioma [J]. Eur J Surg Oncol, 2003, 29(3):278-283.
doi: 10.1053/ejso.2002.1413
[8] Sbardella E, Grossman AB. Pheochromocytoma: An approach to diagnosis [J]. Best Pract Res Clin Endocrinol Metab, 2020, 34(2):101346.
doi: S1521-690X(19)30097-1 pmid: 31708376
[9] Sonbare DJ, Abraham DT, Rajaratnam S, et al. Re-operative surgery for pheochromocytoma-paraganglioma: Analysis of 13 cases from a single institution [J]. Indian J Surg, 2018, 80(2):123-127.
doi: 10.1007/s12262-017-1658-3 pmid: 29915477
[10] Aggeli C, Nixon AM, Parianos C, et al. Surgery for pheochromocytoma: A 20-year experience of a single institution [J]. Hormones (Athens), 2017, 16(4):388-395.
[11] Hassan T, de la Taille A, Ingels A. Right robot-assisted partial adrenalectomy for pheochromocytoma with video [J]. J Visc Surg, 2020, 157(3):259-260.
doi: S1878-7886(20)30057-6 pmid: 32198067
[12] Soejima Y, Yoshizumi T, Ikegami T, et al. Surgical resection of giant pheochromocytomas arising behind the retrohepatic inferior vena cava [J]. Anticancer Res, 2017, 37(1):277-280.
pmid: 28011503
[1] Yuqing LI,Biao WANG,Peng QIAO,Wei WANG,Xing GUAN. Medium to long-term efficacy of tension-free vaginal tape procedure in the treatment of female recurrent stress urinary incontinence [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 600-604.
[2] Chieko MORIMOTO,Yi-qin WANG,Rong ZHOU,Jian-liu WANG. Clinical analysis of fertility-sparing therapy of patients with complex atypical hyperplasia and endometrial cancer [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 936-942.
[3] Yue WANG,Shuang ZHANG,Hong ZHANG,Li LIANG,Ling XU,Yuan-jia CHENG,Xue-ning DUAN,Yin-hua LIU,Ting LI. Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 853-862.
[4] Su-hua CHEN,Jun YANG,Xin CHEN,Chen-long YANG,Jian-jun SUN,Guo-zhong LIN,Tao YU,Xin YANG,Yun-feng HAN,Chao WU,Yu SI,Kai-ming MA. Surgical treatment of large and giant recurrent meningiomas near the middle and posterior third part of the superior sagittal sinus with extracranial invading [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1006-1012.
[5] Yan-fang JIANG,Jian WANG,Yong-jian WANG,Jia LIU,Yin PEI,Xiao-peng LIU,Ying-fang AO,Yong MA. Mid-to-long term clinical outcomes and predictors after anterior cruciate ligament revision [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 857-863.
[6] Huan-bin YU,Wen-jie WU,Xiao-ming LV,Yan SHI,Lei ZHENG,Jian-guo ZHANG. 125I seed brachytherapy for recurrent salivary gland carcinoma after external radiotherapy [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 919-923.
[7] Lu LIU,Jie TIAN,Kai WU,Ying GAO,Zheng ZHANG,Jun-qing ZHANG,Xiao-hui GUO. Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 614-620.
[8] Xu-chu ZHANG,Jian-hua ZHANG,Rong-fu WANG,Yan FAN,Zhan-li FU,Ping YAN,Guang-yu ZHAO,Yan-xia BAI. Diagnostic value of 18F-FDG PET/CT and tumor markers (CEA, CA19-9, CA24-2) in recurrence and metastasis of postoperative colorectal moderately differentiated adenocarcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1071-1077.
[9] Qi TANG,Rong-cheng LIN,Lin YAO,Zheng ZHANG,Han HAO,Cui-jian ZHANG,Lin CAI,Xue-song LI,Zhi-song HE,Li-qun ZHOU. Clinicopathologic features and prognostic analyses of locally recurrent renal cell carcinoma patients after initial surgery [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 628-631.
[10] WU Kai1 ZHANG Yang, ZHANG Hong, TAN Zeng-huan2 GUO Xiao-hui, YANG Jian-mei. Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 634-639.
[11] XING Yun-chao, XIONG Geng-yan, FANG Dong, ZHANG Zheng, CAI Lin, ZHANG Lei, HE Zhi-song, LI Xue-song, ZHOU Li-qun. Preoperative prognostic factors and preoperative risk stratification of upper tract urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 1032-1037.
[12] YANG Ying-chao, LIU Guo-li, ZHOU Jing-wei, HU Hao, SHEN Dan-hua. Diagnosis and treatment of pheochromocytoma in pregnancy: a case report [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 370-372.
[13] WANG Zi-yun, WU Xin-bao. Anterior dislocation of the fibula resulting from surgical malreduction: a case report [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 361-365.
[14] ZHOU Hua, SUN Yu, WANG Shao-bo, ZHANG Feng-shan, ZHANG Li, PAN Sheng-fa, ZHOU Fei-fei. Reoperation for cervical myelopathy duo to progressing ossification of the posterior longitudinal ligaments in patients with expansive laminoplasty [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 210-214.
[15] LIU Yu-Qing, LU Jian, ZHAO Lei, HOU Xiao-Fei, MA Lu-Lin. Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 605-610.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!